ASH: Roche's an­ti­body-drug con­ju­gate Po­livy added to chemo-an­ti­body com­bo boosts sur­vival in ear­ly-stage lym­phoma

Break­throughs in drug de­vel­op­ment have be­gun to un­lock the po­ten­tial of an­ti­body-drug con­ju­gates, ther­a­pies de­signed to bet­ter tar­get pro­teins on tu­mor cells. Genen­tech’s Po­livy has …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER